Joan-En Lin

Title: Innovations by Joan-En Lin in Ocular Drug Delivery

Introduction

Joan-En Lin is a prominent inventor based in Tustin, CA, who has made significant contributions to the field of ocular drug delivery. With a focus on biocompatible intraocular implants, she has developed innovative solutions aimed at treating various ocular conditions. Joan-En Lin holds 2 patents that showcase her expertise and dedication to advancing medical technology.

Latest Patents

One of her latest patents is titled "Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods." This invention involves biocompatible intraocular implants that incorporate a tyrosine kinase inhibitor and a biodegradable polymer. The design facilitates the extended release of the inhibitor into the eye, effectively treating or reducing the occurrence of ocular conditions. Another notable patent is "Intraocular drug delivery systems," which describes biodegradable implants suitable for implantation in ocular regions. These implants provide an extended release of an active agent for a therapeutically effective duration, ranging from 10 days to over a year.

Career Highlights

Joan-En Lin is currently associated with Allergan, Inc., where she continues to innovate in the field of ocular health. Her work has been instrumental in developing advanced drug delivery systems that enhance patient outcomes.

Collaborations

Joan-En Lin has collaborated with notable colleagues, including Patrick Michael Hughes and Thomas C Malone, contributing to a dynamic research environment that fosters innovation.

Conclusion

Joan-En Lin's contributions to ocular drug delivery through her patents and work at Allergan, Inc. highlight her role as a leading inventor in the field. Her innovative approaches are paving the way for improved treatments for ocular conditions.